Literature DB >> 25892351

Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts.

Guy G Brusselle1, Ken Bracke2, Lies Lahousse3.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25892351     DOI: 10.1016/S2213-2600(15)00145-9

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

Review 1.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

Review 2.  Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.

Authors:  Konstantinos Kostikas; Caterina Brindicci; Francesco Patalano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 3.  Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short.

Authors:  Claudio Tantucci; Laura Pini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-04-20

4.  The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.

Authors:  Guy Brusselle; David Price; Kevin Gruffydd-Jones; Marc Miravitlles; Dorothy L Keininger; Rebecca Stewart; Michael Baldwin; Rupert C Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-15

5.  Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).

Authors:  James D Chalmers; Chris Poole; Samantha Webster; Abigail Tebboth; Scott Dickinson; Alicia Gayle
Journal:  Respir Res       Date:  2018-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.